EpiSwitch PSE

EpiSwitch PSE

Biotechnology Research

For the latest news and updates about EpiSwitch PSE, follow our new LinkedIn page @94percent.com

About us

The EpiSwitch® Prostate Screening Test (PSE) is a new prostate cancer blood test that boosts the accuracy of a PSA test to 94%. PSE gives confidence in determining who should proceed to biopsy and who can be placed on surveillance without additional testing. 1 in 8 men will get prostate cancer in their lifetime. If you are being screened for prostate cancer, talk to your primary care doctor about the PSE site www.94percent.com For the latest information, follow us @94percent_com on Twitter.

Website
www.94percent.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Oxford

Updates

Affiliated pages

Similar pages